BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35934012)

  • 1. Epidemiological approach to ending tuberculosis in high-burden countries.
    Marks GB; Horsburgh CR; Fox GJ; Nguyen TA
    Lancet; 2022 Nov; 400(10365):1750-1752. PubMed ID: 35934012
    [No Abstract]   [Full Text] [Related]  

  • 2. Ending TB in Southeast Asia: current resources are not enough.
    Bhatia V; Srivastava R; Reddy KS; Sharma M; Mandal PP; Chhabra N; Jhalani S; Mandal S; Arinaminpathy N; Aditama TY; Sarkar S
    BMJ Glob Health; 2020; 5(3):e002073. PubMed ID: 32201625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investing in improved performance of national tuberculosis programs reduces the tuberculosis burden: analysis of 22 high-burden countries, 2002-2009.
    Akachi Y; Zumla A; Atun R
    J Infect Dis; 2012 May; 205 Suppl 2():S284-92. PubMed ID: 22457297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health systems performance in managing tuberculosis: analysis of tuberculosis care cascades among high-burden and non-high-burden countries.
    Kim J; Keshavjee S; Atun R
    J Glob Health; 2019 Jun; 9(1):010423. PubMed ID: 31263546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiology and control of tuberculosis in Italy].
    Girardi E
    G Ital Med Lav Ergon; 2010; 32(3):256-9. PubMed ID: 21061705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ending tuberculosis in risk groups in Europe: challenges from travel and population movement.
    Jackson C; Abubakar I
    Euro Surveill; 2017 Mar; 22(12):. PubMed ID: 28367797
    [No Abstract]   [Full Text] [Related]  

  • 7. Mitigating the impact of the COVID-19 pandemic on progress towards ending tuberculosis in the WHO South-East Asia Region.
    Bhatia V; Mandal PP; Satyanarayana S; Aditama TY; Sharma M
    WHO South East Asia J Public Health; 2020 Sep; 9(2):95-99. PubMed ID: 32978339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Fund replenishment brings us one step closer to ending tuberculosis.
    Reid M; Von Zinkernagel D; Beyeler N; Goosby E
    Lancet Glob Health; 2019 Dec; 7(12):e1607-e1608. PubMed ID: 31606326
    [No Abstract]   [Full Text] [Related]  

  • 9. WHO's End TB Strategy: From stopping to ending the global TB epidemic.
    Uplekar M; Raviglione M
    Indian J Tuberc; 2015 Oct; 62(4):196-9. PubMed ID: 26970458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis Continued as Global Challenge Though the Burden Remained High in Low-Income and High-Income Countries.
    Haileamlak A
    Ethiop J Health Sci; 2018 Sep; 28(5):517-518. PubMed ID: 30607065
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of basic tools for planning an efficient tuberculosis programme in developed countries based on recent epidemiological studies.
    Styblo K
    Rev Med Suisse Romande; 1982 Mar; 102(3):241-7. PubMed ID: 7100726
    [No Abstract]   [Full Text] [Related]  

  • 12. Global DOTS Expansion Plan. Progress in tuberculosis control in high-burden countries, 2001.
    Wkly Epidemiol Rec; 2001 Jun; 76(24):181-3. PubMed ID: 11431979
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advances in epidemiological research in tuberculosis.
    Styblo K
    Adv Tuberc Res; 1980; 20():1-63. PubMed ID: 7395639
    [No Abstract]   [Full Text] [Related]  

  • 14. Ending tuberculosis by 2030-Pipe dream or reality?
    Chakaya JM; Harries AD; Marks GB
    Int J Infect Dis; 2020 Mar; 92S():S51-S54. PubMed ID: 32114202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aiming for zero tuberculosis transmission in low-burden countries.
    Marais BJ; Walker TM; Cirillo DM; Raviglione M; Abubakar I; van der Werf MJ; Boehme C; Niemann S; Castro KG; Zumla A; Sintchenko V; Crook DW
    Lancet Respir Med; 2017 Nov; 5(11):846-848. PubMed ID: 29033268
    [No Abstract]   [Full Text] [Related]  

  • 16. [Global approach to controlling HIV-associated tuberculosis].
    Nann P
    Probl Tuberk Bolezn Legk; 2005; (10):13-6. PubMed ID: 16318253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location, location, location: tuberculosis services in highest burden countries.
    Huddart S; MacLean E; Pai M
    Lancet Glob Health; 2016 Dec; 4(12):e907-e908. PubMed ID: 27855868
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to 'The Green Light Committee could contribute to ending tuberculosis´.
    Yassin M; Grzemska M
    Int J Tuberc Lung Dis; 2020 Sep; 24(9):984. PubMed ID: 33156773
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidemiological and clinical study of tuberculosis in the Kolin district, Czechoslovakia.
    Dankova D
    Bull Int Union Tuberc Lung Dis; 1991 Dec; 66(4):187-8. PubMed ID: 1687512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameters that influence the prediction of epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnosis.
    Vani J; Maddur MS; Lacroix-Desmazes S; Kaveri SV; Bayry J
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):E129; author reply E130. PubMed ID: 19858487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.